News Snapshot:
By Stabroek News July 4, 2020 SAO PAULO, (Reuters) – Brazilian health regulator Anvisa on Friday approved clinical trials of a potential coronavirus vaccine developed by China’s Sinovac, according to an official gazette publication. The study – first announced on June 11 – is led by Instituto Butantan, a research center funded by the state of Sao Paulo. The agreement with Sinovac includes not only trials but also the transference of technology to produce the potential vaccine locally. On June 29, Sao Paulo state Governor Joao Doria said 9,000 volunteers have already been registered to test the vaccine against COVID-19,...
